Stock listing

NASDAQ:PLSE Pulse Biosciences, Inc Stock

Home listing (NASDAQ) of Pulse Biosciences, Inc

Follow Pulse Biosciences, Inc into a list and get an email when it puts out news.

Share price · NASDAQ:PLSE

$45.55 USD -0.28 (-0.6%)

Close on Nov 20, 2026

Past year +259.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$43.84 – $46.00 USDNov 20, 2026
Volume
466,798 sharesNov 20, 2026
Market cap
$3.35B USDAt the close on Nov 20, 2026 · price × 73.55M shares outstanding
52-week range
$12.70 – $58.94 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$25.81M USDMedian day 450,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Pulse Biosciences, Inc logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PLSE · Home$45.55 USD-0.28 (-0.6%)466,798$44.01$46.00$43.84$45.83Close on Nov 20, 2026
Frankfurt:6L8€41.40 EUR+0.40 (+1.0%)—€39.80€41.40€39.80€41.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PLSE · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$45.55-0.28-0.6%$44.01$46.00$43.84466,798
$45.83+0.99+2.2%$44.36$46.46$43.27331,732
$44.84-1.52-3.3%$46.16$46.29$43.14628,284
$46.36-4.08-8.1%$49.53$51.56$46.03487,183
$50.44-1.81-3.5%$52.53$54.25$50.23590,639
$52.25-4.73-8.3%$56.59$56.81$52.10355,968
$56.98+1.86+3.4%$55.36$57.07$53.97357,535
$55.12-3.05-5.2%$58.00$58.00$51.85496,091
$58.17+4.88+9.2%$53.36$58.94$53.36534,487
$53.29+0.22+0.4%$56.87$56.87$50.31428,196
$53.07-3.99-7.0%$56.01$57.72$50.80534,198
$57.06+4.86+9.3%$52.96$58.17$52.86499,335
$52.20-0.70-1.3%$53.42$55.20$51.64386,074
$52.90+0.66+1.3%$52.40$53.85$51.32249,693
$52.24-3.24-5.8%$54.33$54.70$51.39466,442
$55.48+1.81+3.4%$53.74$56.51$53.74344,676
$53.67+0.47+0.9%$53.12$54.73$52.76279,982
$53.20+0.54+1.0%$53.42$53.77$52.49328,950
$52.66-0.36-0.7%$52.75$53.60$52.07282,470
$53.02+0.34+0.6%$52.44$55.00$51.47453,000
$52.68+1.37+2.7%$50.92$53.67$50.00421,400
$51.31+0.47+0.9%$51.16$52.03$50.07315,600
$50.84+3.29+6.9%$47.25$52.33$47.25385,900
$47.55+3.12+7.0%$44.58$48.12$44.58342,500
$44.43-1.16-2.5%$45.49$46.67$43.32327,400
$45.59-0.73-1.6%$45.13$46.67$43.96425,600
$46.32-2.22-4.6%$47.60$48.97$44.80440,300
$48.54-3.91-7.5%$53.02$53.21$48.01455,500
$52.45-1.36-2.5%$53.53$53.98$50.15434,400
$53.81+3.83+7.7%$49.98$53.97$49.98365,800
$49.98+0.89+1.8%$48.90$50.32$47.31315,600
$49.09-0.66-1.3%$49.11$49.93$48.13409,500
$49.75-0.75-1.5%$51.26$51.26$48.62421,400
$50.50+2.60+5.4%$47.89$50.99$47.47433,400
$47.90-1.93-3.9%$50.13$50.71$47.75519,100
$49.83-0.09-0.2%$49.49$51.56$49.12450,300
$49.92-0.97-1.9%$51.18$51.27$49.17604,600
$50.89-1.43-2.7%$52.24$52.74$48.92516,900
$52.32+0.69+1.3%$51.63$53.60$51.14374,400
$51.63-0.20-0.4%$52.17$54.05$50.80664,000
$51.83-0.15-0.3%$52.18$53.61$51.62666,900
$51.98-0.71-1.3%$53.75$56.74$51.87550,600
$52.69-0.62-1.2%$53.23$53.79$52.49372,200
$53.31-0.56-1.0%$53.97$54.81$51.74382,200
$53.87+3.26+6.4%$50.61$54.29$50.25867,500
$50.61+1.00+2.0%$49.46$53.55$49.01571,900
$49.61-5.59-10.1%$52.55$54.24$48.611,036,200
$55.20+0.99+1.8%$54.42$56.61$53.51472,200
$54.21+1.10+2.1%$52.30$55.78$51.60505,800
$53.11-1.32-2.4%$54.50$56.61$50.32664,300
$54.43+1.46+2.8%$52.18$57.94$51.30915,500
$52.97+4.18+8.6%$49.76$58.90$48.431,560,400
$48.79-4.45-8.4%$52.93$53.11$47.70769,300
$53.24-1.47-2.7%$53.68$54.75$52.75515,200
$54.71+2.03+3.9%$53.79$55.37$53.11702,800
$52.68+0.59+1.1%$52.14$53.57$51.45977,800
$52.09+1.76+3.5%$49.93$54.39$49.161,132,900
$50.33+2.76+5.8%$48.02$50.61$47.57657,300
$47.57-0.99-2.0%$48.06$49.00$47.01262,700
$48.56+0.46+1.0%$47.73$49.95$47.55260,100
$48.10-0.90-1.8%$49.00$49.74$47.93270,100
$49.00-0.13-0.3%$49.73$50.90$47.65366,678
$49.13-1.29-2.6%$50.34$50.34$46.34345,885
$50.42+2.57+5.4%$47.47$50.71$47.47452,800
$47.85+0.83+1.8%$46.76$48.58$46.64238,600
Ticker
NASDAQ:PLSE
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Pulse Biosciences, Inc news

Pulse Biosciences, Inc on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
43 in the last 12 months · 198 in all · newest Nov 20, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Nov 5, 2026
Decks
11 decks · latest Aug 6, 2026

Where Pulse Biosciences, Inc is listed

ListingExchangeCountryCurrency
NASDAQ:PLSE · Home listing · This pageNASDAQUnited StatesUSD
gettex:6L8gettexGermanyEUR
LS Exchange:A2AMY9LS ExchangeGermanyEUR
BOATS:PLSEBOATSUnited StatesUSD
Lang & Schwarz:A2AMY9Lang & SchwarzGermanyEUR
Frankfurt:6L8FrankfurtGermanyEUR
Tradegate:6L8TradegateGermanyEUR
Dusseldorf:6L8DusseldorfGermanyEUR
Munich:6L8MunichGermanyEUR
Stuttgart:6L8StuttgartGermanyEUR
Hamburg:6L8HamburgGermanyEUR
Hanover:6L8HanoverGermanyEUR
Xetra:6L8XetraGermanyEUR

Valuation

EV/sales 2,120× against a median of 3.6×: 10th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$3.17B USD
P/E
Loss
EV/sales
2,120×
EV/EBITDA
Negative EBITDA
Price/book
18.3×
Gross margin
9.4%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta vs S&P 500
1.54

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Pulse Biosciences, Inc · NASDAQ:PLSEUS$3.35BUS$3.17Bn/a2,120×n/a18.3×n/a0.0×1.54
IMEIK Technology Development Co., Ltd. Class A · SZSE:300896US$3.67BUS$3.13B24.8×9.0×n/a3.1×42.4%0.0×n/a
Envista Holdings Corporation · NYSE:NVSTUS$3.67BUS$3.94B5.8×1.4×4.7×1.2×22.0%0.5×1.18
Shandong Weigao Blood Purification Products Co., Ltd. Class A · SSE:603014US$3.53BUS$2.97B23.4×3.7×n/a2.2×18.6%0.0×n/a
Axogen, Inc. · NASDAQ:AXGNUS$3.33BUS$2.98Bn/a11.2×n/a6.7×−12.0%0.0×0.98
Zhende Medical Co., Ltd. Class A · SSE:603301US$3.23BUS$3.13B73.1×4.5×n/a3.8×6.3%0.1×n/a
Lepu Medical Technology (Beijing) Co., Ltd. Class A · SZSE:300003US$3.09BUS$3.03B31.4×3.3×n/a1.3×10.7%0.2×n/a
Carl Zeiss Meditec AG · XETR:AFXUS$3.06BUS$3.06B23.9×1.1×n/a1.3×4.4%0.0×n/a
Imricor Medical Systems, Inc. · ASX:IMRUS$2.99BUS$2.96Bn/a9,790×n/a103×n/a1.2×n/a
TransMedics Group, Inc. · NASDAQ:TMDXUS$2.96BUS$2.52B20.5×3.5×19.8×5.4×19.9%0.1×1.31
Ambu A/S Class B · OMXCOP:AMBU_BUS$2.92BUS$2.92B30.9×3.1×15.9×3.2×9.9%0.1×n/a
Median of the othersUS$3.16BUS$3.00B24.4×3.6×15.9×3.2×10.7%0.1×1.18

Forecasts

5 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
67.67 USD · Analysts' mean
EPS, year to Dec 2026
-1.05 · 3 analysts
Revenue, year to Dec 2026
1.77M · 5 analysts

Team and board

Officers

OfficerRole
Kevin DanahyPresident and Chief Executive Officer
Liane TeplitskyChief Operating Officer
David KenigsbergChief Medical Officer of Electrophysiology
Niv AdChief Science Officer, Cardiac Surgery

Board

DirectorRole
Maria SainzBoard Member

Events

Calls

CallWhenStatus
Pulse Biosciences (NASDAQ:PLSE) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q2 2026 Earnings CallThu, Aug 06, 2026 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q1 2026 Earnings CallThu, May 07, 2026 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q4 2025 Earnings CallThu, Feb 19, 2026 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q3 2025 Earnings CallWed, Nov 05, 2025 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q2 2025 Earnings CallTue, Aug 12, 2025 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q1 2025 Earnings CallThu, May 08, 2025 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q4 2024 Earnings CallThu, Mar 27, 2025 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q3 2024 Earnings CallWed, Oct 30, 2024 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q2 2024 Earnings CallMon, Aug 12, 2024 · 4:30 PM ETReplay
All 25 calls
CallWhenStatus
Pulse Biosciences (NASDAQ:PLSE) Q1 2024 Earnings CallTue, May 07, 2024 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q4 2023 Earnings CallThu, Mar 28, 2024 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q3 2023 Earnings CallMon, Nov 13, 2023 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q2 2023 Earnings CallThu, Aug 10, 2023 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q1 2023 Earnings CallThu, May 11, 2023 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q4 2022 Earnings CallThu, Mar 30, 2023 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q3 2022 Earnings CallThu, Nov 10, 2022 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q2 2022 Earnings CallWed, Aug 10, 2022 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q1 2022 Earnings CallWed, May 11, 2022 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q4 2021 Earnings CallThu, Mar 31, 2022 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q3 2021 Earnings CallMon, Nov 15, 2021 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q2 2021 Earnings CallMon, Aug 09, 2021 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q1 2021 Earnings CallMon, May 10, 2021 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q4 2020 Earnings CallMon, Feb 22, 2021 · 4:30 PM ETReplay
Pulse Biosciences (NASDAQ:PLSE) Q3 2020 Earnings CallMon, Nov 09, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close+0.4%
Q2 2026Aug 6, 2026 · After close+10.9%
Q1 2026May 4, 2026−10.5%
Q4 2025Feb 19, 2026 · After close−14.6%
Q3 2025Nov 5, 2025 · After close−3.3%
Q2 2025Aug 12, 2025 · After close+11.2%
Q1 2025May 5, 2025 · Before open−3.5%
Q4 2024Mar 26, 2025 · Before open−0.3%
Q3 2024Oct 30, 2024 · After close−1.6%
Q2 2024Aug 19, 2024 · After close−3.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · After close−9.2%
Q4 2023Mar 28, 2024 · After close−8.3%
Q3 2023Nov 13, 2023 · Before open+4.8%
Q2 2023Aug 10, 2023 · After close+5.6%
Q1 2023May 11, 2023 · After close+6.3%
Q4 2022Mar 30, 2023 · After close+35.5%
Q3 2022Nov 10, 2022 · After close−1.9%
Q2 2022Aug 10, 2022 · After close+1.8%
Q1 2022May 11, 2022 · After close−23.3%
Q4 2021Mar 31, 2022 · After close−26.9%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings15 slidesAug 6, 2026
Investor Presentation (April 2026)Investor deck14 slidesApr 25, 2026
Investor Presentation (April 2026)Investor deck18 slidesApr 16, 2026
Investor Presentation (March 2026)Investor deck16 slidesMar 3, 2026
Investor Presentation (January 2026)Investor deck17 slidesJan 14, 2026
J.P. Morgan Healthcare Conference 2025Conference31 slidesJan 14, 2025
Investor Presentation (August 2024)Investor deck27 slidesAug 12, 2024
Investor Presentation (January 2024)Investor deck17 slidesJan 9, 2024
Investor Presentation (July 2023)Investor deck20 slidesJul 20, 2023
IPO Roadshow (April 2016)IPO roadshow27 slidesApr 19, 2016
All 11 decks
DeckKindSlidesDate
IPO Roadshow (March 2016)IPO roadshow28 slidesMar 28, 2016

Open Decks

Financings

RaiseDate
At-the-market programme of common stock
Tranche closed: US$95.8M raised
Nov 5, 2026
At-the-market programme of common stock
Announced: US$75M
Use of proceeds: Financing flexibility through key clinical and regulatory milestones
Aug 6, 2026
At-the-market programme of common stock
Tranche closed: US$10.7M raised
Aug 6, 2026
Common stock on exercise of warrants
Closed: US$1.8M raised
Aug 6, 2026
Warrant exercise of 150% common stock warrants
Announced: US$11 a share
Dec 23, 2024
Warrant exercise of warrants exercised for common stock
Closed: US$58.4M raised
Buyers: Robert W. Duggan (exercised all warrants, corresponding to $58.4 million and 5,306,156 shares)
Insiders: Co-Chairman and majority shareholder Robert W. Duggan exercised all of the warrants he acquired in the 2024 rights offering
Dec 19, 2024

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$4.00 a share on May 17, 2016.

Price
US$4.00 a share
Shares offered
5,000,000 shares of common stock
Offering size
US$20 million · Shares offered times the price, worked out by 6ix
Underwriters
MDB Capital Group, LLC, Feltl and Company · In the order on the cover
Shares delivered
On or about May 23, 2016

Steps

StepWhen
Filed publiclyDec 22, 2015
Amended 3 timesNewest May 3, 2016
Shares registered with an exchangeApr 15, 2016
Declared effective by the SECMay 13, 2016
Final prospectus, with the priceMay 17, 2016

Open IPO · From the cover of the final prospectus (424B3) filed May 17, 2016

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue350.0K00700.0K1.42M000247.0K68.0K
Cost of revenue539.0K0011.9M1.97M0600.0K600.0K800.0K500.0K
Gross profit-1.26M-1.18M-1.21M-11.2M-550.0K-1.09M-666.0K-665.0K-665.0K-665.0K
Research and development44.7M32.3M27.8M20.8M28.6M26.4M25.0M17.3M9.65M5.51M
Selling, general and administrative32.0M23.9M15.8M14.0M19.1M22.9M22.3M20.0M15.5M2.93M
Operating income-76.9M-56.3M-43.6M-58.1M-63.0M-50.0M-48.0M-37.5M-25.6M-9.52M
Depreciation and amortization406.0K512.0K542.0K690.0K480.0K430.0K494.0K645.0K336.0K94.0K
EBITDA-76.5M-55.7M-43.0M-57.4M-62.5M-49.5M-47.5M-36.9M-25.2M-9.42M
Interest expense1.10M448.0K646.0K00000
Income before tax72.8M53.6M-42.2M-58.5M-63.7M-49.9M-47.0M-37.5M-25.6M-9.52M
Income tax000000-983.0K-28.0K-912.0K-94.0K
Net income-72.8M-53.6M-42.2M-58.5M-63.7M-49.9M-47.0M-37.5M-25.6M-9.52M
Earnings per share, basic-1.08-0.92-0.85-1.72-2.28-2.14-2.26-2.20-1.73-0.86
Earnings per share, diluted-2.28-2.14-2.26-2.20-1.73-0.86

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents80.7M118.0M44.4M61.1M44.4M12.5M6.90M51.1M3.39M2.09M
Short-term investments08.01M18.5M8.48M34.7M14.3M
Receivables274.0K0061.0K0
Inventory136.0K005.82M000
Current assets83.4M119.4M45.3M62.1M45.3M22.3M26.4M60.4M38.5M16.7M
Property, plant and equipment1.05M1.16M1.53M1.96M1.53M2.48M2.57M2.17M2.57M317.0K
Goodwill2.79M2.79M2.79M2.79M2.79M2.79M2.79M2.79M2.79M2.79M
Total assets94.5M132.5M59.2M77.9M59.2M41.3M41.9M70.6M49.8M26.3M
Accounts payable2.78M1.67M1.84M1.57M1.84M1.72M1.96M1.27M782.0K265.0K
Current liabilities7.92M10.1M6.71M5.98M6.71M7.58M4.46M3.11M2.21M1.02M
Long-term debt65.0M00
Total debt7.53M8.90M9.14M76.0M11.3M11.4M6.72M
Total liabilities13.9M17.6M14.8M80.1M14.8M18.4M11.2M4.31M3.83M1.02M
Shareholders' equity80.7M114.9M44.4M-2.25M44.4M22.9M30.7M66.3M46.0M25.3M
Shares outstanding67.8M65.9M55.1M37.2M55.1M25.6M20.8M20.6M16.8M13.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-54.1M-36.3M-33.0M-47.0M-54.1M-35.4M-34.2M-23.9M-11.1M-8.05M
Capital spending-315.0K-125.0K-121.0K-401.0K-437.0K-441.0K-608.0K-276.0K-2.55M-64.0K
Free cash flow-54.4M-36.5M-33.2M-47.4M-54.5M-35.8M-34.8M-24.2M-13.6M-8.12M
Cash from investing-335.0K-125.0K-121.0K-401.0K7.56M10.0M-10.1M26.1M-23.0M-14.4M
Cash from financing17.2M110.1M16.4M79.9M62.7M30.9M82.0K45.5M35.4M20.9M
Dividends paid-810.0K-619.0K00
Share buybacks586.0K478.0K395.0K486.0K810.0K490.0K-613.0K-115.0K35.4M20.9M
Change in cash-37.3M73.7M-16.8M32.5M16.2M5.56M-44.2M47.7M1.30M-1.52M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 6, 2026Current reportSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
8-K · Current reportOct 14, 2026Current reportSEC
8-K · Current reportOct 7, 2026Current reportSEC
8-K · Current reportSep 15, 2026Material contractSEC
424B5 · ProspectusSep 15, 2026Offer documentSEC
8-K · Current reportSep 15, 2026Current reportSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 28, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 28, 2026Insider tradeSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
3 · Initial statement of ownershipAug 28, 2026Insider tradeSEC
8-K · Current reportAug 6, 2026Material contractSEC
424B5 · ProspectusAug 6, 2026Offer documentSEC
10-Q · Quarterly reportAug 6, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
8-K · Current reportJul 29, 2026Current reportSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
8-K · Current reportJun 12, 2026Meeting outcomeSEC
8-K · Current reportJun 10, 2026Current reportSEC
4/A · Change in ownership, amendedMay 15, 2026Insider tradeSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 13, 2026Big-stake noticeSEC
4/A · Change in ownership, amendedMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
DEF 14A · Proxy statementMay 11, 2026Meeting noticeSEC
8-K · Current reportMay 6, 2026Current reportSEC
8-K · Current reportMay 4, 2026ResultsSEC
10-K/A · Annual report, amendedApr 30, 2026Annual reportSEC
8-K · Current reportApr 27, 2026Current reportSEC
8-K · Current reportApr 16, 2026Current reportSEC
8-K · Current reportApr 9, 2026Management or board changeSEC
8-K · Current reportApr 7, 2026Current reportSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
8-K · Current reportMar 27, 2026Management or board changeSEC
8-K · Current reportMar 17, 2026Current reportSEC
8-K · Current reportMar 12, 2026Current reportSEC
8-K · Current reportMar 9, 2026Current reportSEC
8-K · Current reportMar 3, 2026Current reportSEC
8-K/A · Current report, amendedMar 2, 2026Management or board changeSEC
EFFECT · Notice that a registration is effectiveMar 2, 2026Other filingsSEC
8-K · Current reportFeb 27, 2026Management or board changeSEC
CORRESP · Letter to the SECFeb 25, 2026Other filingsSEC
UPLOAD · Letter from the SECFeb 25, 2026Other filingsSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
8-K · Current reportFeb 19, 2026ResultsSEC
S-3 · Registration statementFeb 19, 2026Offer documentSEC
S-8 · Registration statement for employee plansFeb 19, 2026Offer documentSEC
424B5 · ProspectusFeb 19, 2026Offer documentSEC
8-K · Current reportFeb 19, 2026Material contractSEC
10-K · Annual reportFeb 19, 2026Annual reportSEC
4 · Change in ownershipFeb 17, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 12, 2026Other filingsSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 9, 2026Other filingsSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 6, 2026Insider tradeSEC
8-K · Current reportFeb 5, 2026Current reportSEC
8-K · Current reportJan 14, 2026Current reportSEC
8-K · Current reportJan 9, 2026Management or board changeSEC
8-K · Current reportDec 18, 2025Current reportSEC
8-K · Current reportDec 12, 2025Meeting outcomeSEC
8-K · Current reportDec 9, 2025Current reportSEC
8-K · Current reportNov 13, 2025Current reportSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
DEF 14A · Proxy statementOct 28, 2025Meeting noticeSEC
DEFA14A · Additional proxy materialOct 27, 2025Meeting noticeSEC
8-K · Current reportOct 24, 2025Current reportSEC
8-K · Current reportOct 10, 2025Current reportSEC
4 · Change in ownershipOct 7, 2025Insider tradeSEC
8-K · Current reportOct 1, 2025Meeting outcomeSEC
4 · Change in ownershipSep 22, 2025Insider tradeSEC
4 · Change in ownershipSep 18, 2025Insider tradeSEC
144 · Notice of proposed saleSep 18, 2025Other filingsSEC
4 · Change in ownershipSep 15, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
144 · Notice of proposed saleSep 11, 2025Other filingsSEC
8-K · Current reportSep 8, 2025Current reportSEC
DEF 14A · Proxy statementSep 2, 2025Meeting noticeSEC
8-K · Current reportSep 2, 2025Current reportSEC
8-K · Current reportAug 26, 2025Current reportSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
PRE 14A · Preliminary proxy statementAug 18, 2025Meeting noticeSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
8-K · Current reportAug 12, 2025ResultsSEC
4 · Change in ownershipJul 16, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 16, 2025Insider tradeSEC
8-K · Current reportJul 14, 2025Management or board changeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
144 · Notice of proposed saleJun 13, 2025Other filingsSEC
144 · Notice of proposed saleJun 12, 2025Other filingsSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
10-K/A · Annual report, amendedApr 30, 2025Annual reportSEC
10-K · Annual reportMar 28, 2025Annual reportSEC
8-K · Current reportMar 28, 2025ResultsSEC
S-8 · Registration statement for employee plansFeb 27, 2025Offer documentSEC
S-8 · Registration statement for employee plansFeb 27, 2025Offer documentSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
8-K · Current reportFeb 4, 2025Management or board changeSEC
8-K · Current reportJan 23, 2025Current reportSEC
8-K · Current reportJan 14, 2025Current reportSEC
4 · Change in ownershipJan 13, 2025Insider tradeSEC
8-K · Current reportJan 13, 2025Management or board changeSEC
8-K · Current reportDec 23, 2024Current reportSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 19, 2024Big-stake noticeSEC
4 · Change in ownershipDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 17, 2024Insider tradeSEC
4 · Change in ownershipDec 17, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
8-K · Current reportDec 6, 2024Management or board changeSEC
8-K · Current reportNov 26, 2024Current reportSEC
8-K · Current reportOct 31, 2024Current reportSEC
10-Q · Quarterly reportOct 30, 2024Quarterly reportSEC
8-K · Current reportOct 30, 2024ResultsSEC
4 · Change in ownershipSep 30, 2024Insider tradeSEC
10-Q · Quarterly reportAug 19, 2024Quarterly reportSEC
NT 10-Q · Late filing noticeAug 15, 2024Explanation requestSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
3 · Initial statement of ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
8-K · Current reportAug 12, 2024Current reportSEC
8-K · Current reportAug 12, 2024ResultsSEC
8-K · Current reportAug 8, 2024Current reportSEC
4 · Change in ownershipJul 22, 2024Insider tradeSEC
8-K · Current reportJul 15, 2024ResultsSEC
424B5 · ProspectusJul 15, 2024Offer documentSEC
S-3MEFJul 15, 2024Other filingsSEC
4 · Change in ownershipJul 9, 2024Insider tradeSEC
4 · Change in ownershipJul 9, 2024Insider tradeSEC
4 · Change in ownershipJul 9, 2024Insider tradeSEC
4 · Change in ownershipJul 8, 2024Insider tradeSEC
4 · Change in ownershipJul 8, 2024Insider tradeSEC
8-K · Current reportJul 8, 2024Current reportSEC
SC 13D/A · Big-stake notice, amendedJul 8, 2024Big-stake noticeSEC
8-K · Current reportJul 3, 2024Current reportSEC
8-K · Current reportJun 28, 2024Current reportSEC
4 · Change in ownershipJun 24, 2024Insider tradeSEC
4 · Change in ownershipJun 24, 2024Insider tradeSEC
4 · Change in ownershipJun 24, 2024Insider tradeSEC
4 · Change in ownershipJun 24, 2024Insider tradeSEC
4 · Change in ownershipJun 24, 2024Insider tradeSEC
8-K · Current reportJun 7, 2024Management or board changeSEC
424B2 · ProspectusJun 4, 2024Offer documentSEC
8-K · Current reportJun 4, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveJun 3, 2024Other filingsSEC
SD · Specialized disclosureMay 31, 2024ESG reportSEC
POS AM · Amendment to an effective registrationMay 28, 2024Offer documentSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
3 · Initial statement of ownershipMay 22, 2024Insider tradeSEC
8-K · Current reportMay 20, 2024Current reportSEC
8-K · Current reportMay 15, 2024Management or board changeSEC
8-K · Current reportMay 9, 2024Current reportSEC
10-Q · Quarterly reportMay 7, 2024Quarterly reportSEC
8-K · Current reportMay 7, 2024ResultsSEC
EFFECT · Notice that a registration is effectiveMay 6, 2024Other filingsSEC
8-K · Current reportMay 2, 2024Current reportSEC
CORRESP · Letter to the SECMay 1, 2024Other filingsSEC
S-3/A · Registration statement, amendedApr 30, 2024Offer documentSEC
CORRESP · Letter to the SECApr 30, 2024Other filingsSEC
S-3/A · Registration statement, amendedApr 25, 2024Offer documentSEC
CORRESP · Letter to the SECApr 25, 2024Other filingsSEC
UPLOAD · Letter from the SECApr 24, 2024Other filingsSEC
DEFA14A · Additional proxy materialApr 23, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 23, 2024Meeting noticeSEC
CORRESP · Letter to the SECApr 23, 2024Other filingsSEC
S-3/A · Registration statement, amendedApr 23, 2024Offer documentSEC
UPLOAD · Letter from the SECApr 18, 2024Other filingsSEC
CORRESP · Letter to the SECApr 15, 2024Other filingsSEC
S-3/A · Registration statement, amendedApr 15, 2024Offer documentSEC
UPLOAD · Letter from the SECApr 10, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 9, 2024Other filingsSEC
CORRESP · Letter to the SECApr 4, 2024Other filingsSEC
S-3 · Registration statementApr 3, 2024Offer documentSEC
UPLOAD · Letter from the SECApr 3, 2024Other filingsSEC
8-K · Current reportMar 28, 2024ResultsSEC
S-3 · Registration statementMar 28, 2024Offer documentSEC
10-K · Annual reportMar 28, 2024Annual reportSEC
8-K · Current reportMar 11, 2024Current reportSEC
8-K · Current reportFeb 14, 2024Current reportSEC
8-K · Current reportJan 9, 2024Current reportSEC
8-K · Current reportJan 2, 2024Current reportSEC
8-K · Current reportDec 22, 2023Meeting outcomeSEC
8-K · Current reportDec 20, 2023Current reportSEC
4 · Change in ownershipDec 14, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedDec 14, 2023Big-stake noticeSEC

This page holds 200 of 642 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Pulse Biosciences, Inc’s releases · as of Nov 19, 2026

Common shares
73,548,924
Fully diluted
73,555,224

Fully diluted

LineSharesAs of
Common shares73,548,924Nov 2, 2026
Options and RSUs6,300Nov 19, 2026

Warrants and options

Lot
Stock options · US$44.41 · expiry not stated

Share count over time

CountShares
Nov 2, 202673,548,924

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
T. Rowe Price2.79M3.8%US$139MSep 30, 2026
BlackRock1.67M2.3%US$83.6MSep 30, 2026
Citadel1.48M2.0%US$74.1MSep 30, 2026
Bank of America1.47M2.0%US$73.2MSep 30, 2026
Vanguard1.35M1.8%US$67.4MSep 30, 2026
Balyasny Asset Management L.P.632K0.86%US$31.5MSep 30, 2026
State Street548K0.75%US$27.4MSep 30, 2026
Geode Capital544K0.74%US$27.2MSep 30, 2026
JPMorgan522K0.71%US$26.6MSep 30, 2026
Sun Life406K0.55%US$20.3MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Holocene Advisors, LP339K0.46%US$16.9MSep 30, 2026
Portolan Capital Management, LLC288K0.39%US$14.4MSep 30, 2026
Point72 Asset Management, L.P.189K0.26%US$9.42MSep 30, 2026
Northern Trust182K0.25%US$9.08MSep 30, 2026
Schwab177K0.24%US$8.81MSep 30, 2026
Lord, Abbett & Co. LLC172K0.23%US$8.61MSep 30, 2026
Federated Hermes, Inc.161K0.22%US$8.04MSep 30, 2026
TD154K0.21%US$7.84MSep 30, 2026
D. E. Shaw & Co., Inc.146K0.20%US$7.31MSep 30, 2026
Griffin Asset Management, Inc.144K0.20%US$7.2MSep 30, 2026
Millennium142K0.19%US$7.06MSep 30, 2026
ExodusPoint Capital Management, LP123K0.17%US$6.16MSep 30, 2026
Panoramic Capital, LLC105K0.14%US$5.22MSep 30, 2026
UBS104K0.14%US$5.21MSep 30, 2026
Invesco101K0.14%US$5.04MSep 30, 2026
Manufacturers Life Insurance Company, The97,5460.13%US$4.87MSep 30, 2026
Nuveen91,8660.12%US$4.59MSep 30, 2026
Westside Investment Management, Inc.74,0290.10%US$3.7MSep 30, 2026
Goldman Sachs66,6420.09%US$3.33MSep 30, 2026
Informed Momentum Co LLC62,5370.09%US$3.12MSep 30, 2026
Morgan Stanley58,9750.08%US$2.94MSep 30, 2026
BNY47,2960.06%US$2.36MSep 30, 2026
Polen Capital Management LLC42,1370.06%US$2.1MSep 30, 2026
Jane Street39,3420.05%US$1.96MSep 30, 2026
Swiss National Bank35,0000.05%US$1.75MSep 30, 2026
Wellington31,2640.04%US$1.56MSep 30, 2026
Ameriprise30,9730.04%US$1.55MSep 30, 2026
Formula Growth LTD30,0000.04%US$1.5MSep 30, 2026
Creative Planning28,6460.04%US$1.43MSep 30, 2026
Squarepoint Ops LLC27,9150.04%US$1.39MSep 30, 2026
Argo Wealth Advisory, LLC27,2640.04%US$1.36MSep 30, 2026
Sectoral Asset Management Inc26,1700.04%US$1.31MSep 30, 2026
Rhumbline Advisers24,2500.03%US$1.21MSep 30, 2026
XTX Topco Ltd23,9910.03%US$1.2MSep 30, 2026
Barclays23,7890.03%US$1.19MSep 30, 2026
DWS23,7390.03%US$1.19MSep 30, 2026
State Of Wisconsin Investment Board23,6530.03%US$1.18MSep 30, 2026
Mangrove Partners Im, LLC23,5820.03%US$1.18MSep 30, 2026
AllianceBernstein23,5000.03%US$1.17MSep 30, 2026
California State Teachers Retirement System22,3170.03%US$1.11MSep 30, 2026

This page holds 50 of 134 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund555K0.75%US$15.4MJun 30, 2026
Strategic Advisers U.S. Total Stock Fund513K0.70%US$12.8MMay 31, 2026
iShares Russell 2000 ETF487K0.66%US$13.5MJun 30, 2026
T. Rowe Price New Horizons Fund, Inc.485K0.66%US$13.5MJun 30, 2026
MFS New Discovery Fund339K0.46%US$8.49MMay 31, 2026
Vanguard Extended Market Index Fund216K0.29%US$5.99MJun 30, 2026
Fidelity Small Cap Index Fund210K0.29%US$7.38MJul 31, 2026
iShares Russell 2000 Growth ETF174K0.24%US$4.83MJun 30, 2026
MFS New Discovery Series122K0.17%US$3.39MJun 30, 2026
Fidelity Extended Market Index Fund94,6280.13%US$2.37MMay 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Russell 2000 Index Fund91,2230.12%US$2.28MMay 31, 2026
Schwab U.S. Small-Cap ETF86,7430.12%US$2.17MMay 31, 2026
iShares Micro-Cap ETF61,9070.08%US$1.72MJun 30, 2026
Vanguard Health Care Index Fund60,5560.08%US$1.51MMay 31, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF53,0190.07%US$1.47MJun 30, 2026
Schwab Small-Cap Index Fund45,0940.06%US$1.58MJul 31, 2026
Fidelity Nasdaq Composite Index Fund41,4690.06%US$1.04MMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF38,9810.05%US$1.08MJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account37,2000.05%US$1.03MJun 30, 2026
Fidelity Total Market Index Fund36,9440.05%US$924KMay 31, 2026
Master Small Cap Index Series34,6860.05%US$962KJun 30, 2026
Fidelity Series Total Market Index Fund27,8890.04%US$697KMay 31, 2026
Inspire Small/Mid Cap ETF25,3600.03%US$634KMay 31, 2026
Nuveen Small Cap Blend Index Fund24,4420.03%US$859KJul 31, 2026
Fidelity Nasdaq Composite Index ETF23,7570.03%US$594KMay 31, 2026
Nuveen Equity Index Fund22,1850.03%US$779KJul 31, 2026
EQ/2000 Managed Volatility Portfolio21,0960.03%US$585KJun 30, 2026
Fidelity Small Cap Growth Index Fund17,3860.02%US$482KJun 30, 2026
Vanguard Russell 2000 Growth Index Fund16,6570.02%US$416KMay 31, 2026
LVIP State Street Small-Cap Index Fund11,5150.02%US$319KJun 30, 2026
EQ/Small Company Index Portfolio11,5100.02%US$319KJun 30, 2026
Schwab U.S. Broad Market ETF10,9230.01%US$273KMay 31, 2026
Fidelity ZERO Total Market Index Fund10,1080.01%US$355KJul 31, 2026
Small Cap Index Fund9,5520.01%US$265KJun 30, 2026
iShares Russell 3000 ETF9,3530.01%US$259KJun 30, 2026
Schwab Total Stock Market Index Fund9,2730.01%US$326KJul 31, 2026
Vanguard Balanced Index Fund9,2400.01%US$256KJun 30, 2026
Vanguard Institutional Total Stock Market Index Fund8,9760.01%US$249KJun 30, 2026
Global X Russell 2000 ETF8,8730.01%US$312KJul 31, 2026
Polen 5Perspectives Small Growth Fund8,6700.01%US$305KJul 31, 2026
Fidelity MSCI Health Care Index ETF8,0790.01%US$284KJul 31, 2026
Fidelity ZERO Extended Market Index Fund6,901<0.01%US$242KJul 31, 2026
Small Cap Index Fund6,809<0.01%US$170KMay 31, 2026
State Street Small/Mid Cap Equity Index Portfolio6,693<0.01%US$186KJun 30, 2026
ATM Small Cap Managed Volatility Portfolio6,429<0.01%US$178KJun 30, 2026
Zacks Small-Cap Core Fund5,927<0.01%US$148KMay 31, 2026
Small Cap Core Fund5,819<0.01%US$161KJun 30, 2026
MetLife Russell 2000 Index Portfolio5,792<0.01%US$161KJun 30, 2026
EQ/AB Small Cap Growth Portfolio5,790<0.01%US$161KJun 30, 2026
Small-Cap Index Portfolio4,917<0.01%US$136KJun 30, 2026

This page holds 50 of 111 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Teplitsky Liane Rae
Officer: Chief Operating Officer
Buy1,001USD 49.95US$50,000Sep 1, 2026
Teplitsky Liane Rae
Officer: Chief Operating Officer
Buy1,024USD 48.80US$49,971Aug 31, 2026
Teplitsky Liane Rae
Officer: Chief Operating Officer
Buy1,034USD 48.35US$49,994Aug 28, 2026
Teplitsky Liane Rae
Officer: Chief Operating Officer
Buy1,036USD 48.24US$49,977Aug 26, 2026
Duggan Robert W
Director, 10% owner
Buy660,233USD 19.69US$13MMay 11, 2026
Laviolette Paul A
Director, Officer: Chief Executive Officer
Buy15,000USD 19.69US$295KMay 11, 2026

Big stakes

StakeStakeSharesDateFiling
ROBERT W. DUGGAN71.90%49.7MMay 11, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Maria Sainz
Other companies: Hyperfine, Inc. (President and CEO · Since at least Dec 22, 2021); ATRION Corporation (Director · Aug 30, 2021 – May 24, 2022 · Past); Shockwave Medical Inc (Director · Jul 16, 2020 – May 31, 2024 · Past); Avanos Medical, Inc. (Director · Jan 2, 2019 – Jan 3, 2022 · Past); IRIDEX Corporation (Director · Apr 13, 2018 – Jul 23, 2019 · Past); Halyard Health Inc (Director · Feb 2, 2015 – May 3, 2018 · Past); ClearPoint Neuro Inc. (Director · Jan 1, 2014 – Mar 30, 2018 · Past); The Spectranetics Corp (Director · Nov 1, 2010 – Aug 9, 2017 · Past); Orthofix Medical Inc. (Director · Jun 19, 2008 – Jun 8, 2020 · Past)
Board Member · Since at least Jan 8, 2026
Manmeet Soni
Other companies: Summit Therapeutics Inc. (Chief Operating Officer, Chief Financial Officer & Director · Since at least Sep 18, 2020); Reata Pharmaceuticals Inc (COO, CFO and President · Aug 28, 2019 – Sep 26, 2023 · Past); Arena Pharmaceuticals Inc (Director · Dec 14, 2018 – Jun 17, 2020 · Past); Alnylam Pharmaceuticals, Inc. (Chief Financial Officer · May 9, 2017 – Feb 28, 2019 · Past); Ariad Pharmaceuticals Inc (EVP, CFO & Treasurer · Mar 21, 2016 – Feb 16, 2017 · Past); Pharmacyclics Inc (Chief Financial Officer · Feb 13, 2013 – May 26, 2015 · Past)
Director · Since at least Nov 2, 2017
Paul A. LaViolette
Other companies: Edwards Lifesciences Corporation (Director · Since at least Jul 13, 2020); Misonix Inc (Director · Sep 27, 2019 – Oct 29, 2021 · Past); Asensus Surgical Inc (Director · Sep 3, 2013 – Jun 30, 2021 · Past); Conceptus Inc (Director · Dec 31, 2008 – Jun 5, 2013 · Past); Baxano Surgical Inc (Director · Aug 7, 2008 – Apr 17, 2014 · Past); Boston Scientific Corporation (COO · Apr 26, 2007 – Jul 1, 2008 · Past)
Chief Executive Officer, Director · Since at least Aug 9, 2024
Sandra A Gardiner
Other companies: Adagio Medical Holdings, Inc (Director · Since at least Jul 31, 2024); Kronos Bio Inc (Interim CFO · Sep 15, 2023 – Sep 15, 2023 · Past); Nektar Therapeutics (Chief Financial Officer · Apr 17, 2023 – Apr 17, 2023 · Past); Anebulo Pharmaceuticals, Inc. (Acting Chief Financial Officer · Mar 2, 2023 – Mar 2, 2023 · Past); Lucira Health Inc (Director · Feb 4, 2021 – Jun 1, 2022 · Past)
CFO & EVP Admin. and Finance · Dec 9, 2020 – Dec 14, 2021 · Past
Richard A. van den Broek
Other companies: Corvus Pharmaceuticals, Inc. (Board Member · Since at least Apr 8, 2025); PhaseBio Pharmaceuticals Inc (Director · Feb 27, 2019 – May 19, 2023 · Past); Celldex Therapeutics, Inc. (Director · Dec 17, 2014 – Jun 8, 2016 · Past); Pharmacyclics Inc (Director · Oct 3, 2011 – May 26, 2015 · Past)
Director · Since at least Aug 6, 2020
Laureen Debuono
Other companies: Rani Therapeutics Holdings, Inc. (Director · Jul 29, 2021 – Dec 16, 2024 · Past); Turtle Beach Corporation (Director · Jan 15, 2014 – Feb 3, 2017 · Past); Cadence Pharmaceuticals Inc (Director · Aug 14, 2013 – Mar 19, 2014 · Past)
Director · Oct 4, 2021 – Oct 4, 2021 · Past
Brian B Dow
Other companies: ProSomnus, Inc. (CHIEF FINANCIAL OFFICER · Mar 1, 2023 – Feb 15, 2024 · Past); Pacific Biosciences of California, Inc. (VP and PAO · Oct 26, 2010 – Mar 2, 2015 · Past)
CFO & SVP Admin. and Finance · May 13, 2016 – May 16, 2017 · Past
Kenneth A. Clark
Other companies: Summit Therapeutics Inc. (Lead Independent Director · Since at least Oct 7, 2021); Pharmacyclics Inc (Director · Nov 9, 2012 – May 26, 2015 · Past)
Director · Nov 2, 2017 – May 20, 2021 · Past
Mahkam Zanganeh
Other companies: Summit Therapeutics Inc. (Co-Chief Executive Officer, Director · Since at least Nov 11, 2020)
Director · Since at least Jan 8, 2021
Steven Weber
Other companies: IGM Biosciences Inc (PRINCIPAL ACCOUNTING OFFICER · Since at least May 25, 2022)
Principal Accounting Officer · Since at least Jul 14, 2025
All 18 people
PersonSeat
Darrin UeckerChief Technology Officer, Director · Since at least Jun 1, 2018
David KenigsbergChief Medical Officer of Electrophysiology · Since at least Oct 7, 2026
Ed EbbersEVP & GM, Dermatology · Jan 11, 2019 – Jun 1, 2021 · Past
Jon SkinnerChief Financial Officer · Since at least Aug 28, 2026
Kevin DanahyPresident and Chief Executive Officer · Since at least Feb 14, 2022
Liane TeplitskyChief Operating Officer · Since at least Apr 8, 2026
Mitchell E LevinsonChief Strategy Officer · May 13, 2016 – Sep 24, 2024 · Past
Niv AdChief Science Officer, Cardiac Surgery · Since at least Oct 24, 2025

Open People

Log in to ask 6ix AI your own questions about Pulse Biosciences, Inc.